NASDAQ: ISPRIspire Technology Inc Stock
$1.87-0.14 (-6.97%)
Updated Oct 31, 2025
ISPR Price
$1.87
Fair Value Price
-$1.65
Market Cap
$107.11M
52 Week Low
$1.87
52 Week High
$7.47
P/E
-2.71x
P/B
177.13x
P/S
1.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$127.49M
Earnings
-$39.24M
Gross Margin
17.8%
Operating Margin
-29.83%
Profit Margin
-30.8%
Debt to Equity
168.04
Operating Cash Flow
-$7M
Beta
1.14
Next Earnings
Nov 18, 2025
Ex-Dividend
N/A
Next Dividend
N/A
ISPR Overview
Ispire Technology Inc. manufactures e-cigarettes and cannabis vaping products. The company was founded in 2019 and is based in Los Angeles, California. Ispire Technology Inc. operates as a subsidiary of Pride Worldwide Investment Limited
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ISPR's potential to beat the market
- ISPR doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Tobacco
Industry Rating
C
ISPR
RankedUnranked of 8
RankedUnranked of 8
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $50.68 | B | |
| $144.33 | B | |
| $51.19 | C |
Be the first to know about important ISPR news, forecast changes, insider trades & much more!
ISPR News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ISPR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ISPR ($1.87) is overvalued by 213.47% relative to our estimate of its Fair Value price of -$1.65 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ISPR ($1.87) is not significantly undervalued (213.47%) relative to our estimate of its Fair Value price of -$1.65 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ISPR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ISPR due diligence checks available for Premium users.
Valuation
ISPR fair value
Fair Value of ISPR stock based on Discounted Cash Flow (DCF)
Price
$1.87
Fair Value
-$1.65
Undervalued by
213.47%
ISPR ($1.87) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ISPR ($1.87) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ISPR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ISPR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.71x
Industry
23.04x
Market
41.65x
ISPR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
177.13x
Industry
8.52x
ISPR is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ISPR's financial health
Profit margin
Revenue
$20.1M
Net Income
-$14.8M
Profit Margin
-73.4%
ISPR's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
ISPR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$102.2M
Liabilities
$101.6M
Debt to equity
168.04
ISPR's short-term assets ($72.91M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ISPR's short-term assets ($72.91M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ISPR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$4.7M
Investing
-$3.5M
Financing
-$425.7k
ISPR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ISPR vs Tobacco Stocks
Ispire Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.